Patents by Inventor Robert K. Naviaux

Robert K. Naviaux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR AUTISM SPECTRUM DISORDER PHARMACOTHERAPY
    Publication number: 20190358181
    Abstract: Disclosed herein are compositions of antipurinergic agents and methods of use thereof for treating cognitive developmental disorders and autism spectrum disorders (ASD) in patients in need thereof.
    Type: Application
    Filed: August 9, 2019
    Publication date: November 28, 2019
    Inventors: Brent VAUGHAN, Robert K. NAVIAUX
  • DIAGNOSTIC AND PREDICTIVE METABOLITE PATTERNS FOR DISORDERS AFFECTING THE BRAIN AND NERVOUS SYSTEM
    Publication number: 20160209428
    Abstract: The disclosure provides for methods that integrate metabolic testing results from a patient's biological sample for predicting or diagnosing neurological disease and disorders.
    Type: Application
    Filed: August 21, 2014
    Publication date: July 21, 2016
    Inventors: Robert K. Naviaux, Dewleen Baker
  • Methods of treatment of mitochondrial disorders
    Patent number: 8748408
    Abstract: In accordance with the present invention, there are provided methods for the treatment of mitochondrial disorders. Invention methods include the administration of a pyrimidine-based nucleoside such as triacetyluridine, or the like. Also provided are methods of reducing or eliminating symptoms associated with mitochondrial disorders. Mitochondrial disorders particularly appropriate for treatment include those attributable to a deficiency of one or more pyrimidines.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: June 10, 2014
    Assignee: The Regents of the University of California
    Inventor: Robert K. Naviaux
  • Methods of Treatment of Mitochondrial Disorders
    Publication number: 20100098678
    Abstract: In accordance with the present invention, there are provided methods for the treatment of mitochondrial disorders. Invention methods include the administration of a pyrimidine-based nucleoside such as triacetyluridine, or the like. Also provided are methods of reducing or eliminating symptoms associated with mitochondrial disorders. Mitochondrial disorders particularly appropriate for treatment include those attributable to a deficiency of one or more pyrimidines.
    Type: Application
    Filed: December 21, 2009
    Publication date: April 22, 2010
    Inventor: Robert K. Naviaux
  • Method of treatment of mitochondrial disorders
    Patent number: 7638501
    Abstract: In accordance with the present invention, there are provided methods for the treatment of mitochondrial disorders. Invention methods include the administration of a pyrimidine-based nucleoside such as triacetyluridine, or the like. Also provided are methods of reducing or eliminating symptoms associated with mitochondrial disorders. Mitochondrial disorders particularly appropriate for treatment include those attributable to a deficiency of one or more pyrimidines.
    Type: Grant
    Filed: February 23, 2000
    Date of Patent: December 29, 2009
    Assignee: The Regents of the University of California
    Inventor: Robert K. Naviaux
  • Methods of treatment of mitochondrial disorders
    Publication number: 20040224920
    Abstract: In accordance with the present invention, there are provided methods for the treatment of mitochondrial disorders. Invention methods include the administration of a pyrimidine-based nucleoside such as triacetyluridine, or the like. Also provided are methods of reducing or eliminating symptoms associated with mitochondrial disorders. Mitochondrial disorders particularly appropriate for treatment include those attributable to a deficiency of one or more pyrimidines.
    Type: Application
    Filed: June 14, 2004
    Publication date: November 11, 2004
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventor: Robert K. Naviaux